Athersys to Present at Stifel 2016 Healthcare Conference in New York
November 03 2016 - 9:00AM
Athersys, Inc. (NASDAQ:ATHX) announced today that Gil Van Bokkelen,
Chairman and CEO, will present at the Stifel 2016 Healthcare
Conference at the Lotte New York Palace Hotel in New York.
The presentation is scheduled for Wednesday, November 16, 2016 at
3:45 pm ET in the Garrison conference room.
A live audio webcast will be available via the
investor relations page of the Athersys website at
www.athersys.com. A replay of the presentation will be archived on
the Athersys website for those unable to listen live.
About Athersys
Athersys is an international biotechnology
company engaged in the discovery and development of therapeutic
product candidates designed to extend and enhance the quality of
human life. The Company is developing its MultiStem® cell therapy
product, a patented, adult-derived "off-the-shelf" stem cell
product, initially for disease indications in the cardiovascular,
neurological, inflammatory and immune disease areas, and has
several ongoing clinical trials evaluating this potential
regenerative medicine product. Athersys has forged strategic
partnerships and collaborations with leading pharmaceutical and
biotechnology companies, as well as world-renowned research
institutions to further develop its platform and products. More
information is available at www.athersys.com.
ATHX-G
Contact:
William (B.J.) Lehmann, J.D.
President and Chief Operating Officer
Tel: (216) 431-9900
bjlehmann@athersys.com
Athersys (NASDAQ:ATHX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Athersys (NASDAQ:ATHX)
Historical Stock Chart
From Sep 2023 to Sep 2024